MMP-9 expression was evaluated in 300 human tumor tissues representative of each molecular subtypes of breast cancer whose definition was based on the use of the following surrogate markers: ER, PR, HER2 and Ki-67 [22]. The gene discussed is ERBB2; the disease is breast carcinoma.